Zeon Corporation Acquires Edge Precision Manufacturing Inc ("Edge"), a leading manufacturer of micro featured thermoplastic devices for diagnostic, clinical, optics, and research applications

10 January 2023 | Tuesday | News

Innovative Materials meets High Precision Micro-Manufacturing, Accelerating the Development of Healthcare and Life Sciences Business

Zeon Corporation (Zeon; head office: Chiyoda-ku, Tokyo; President and CEO: Kimiaki Tanaka), through its subsidiary Zeon Specialty Materials Inc. (California, U.S.A.; representative: Hirokazu Matsumoto), has purchased 100% of the shares of Edge Precision Manufacturing, Inc. (Massachusetts, U.S.A.; representative: Andrew Kamholz), a manufacturer of micro featured thermoplastic devices, from shareholders including venture capital funds managed by U.S. investment company Anzu Partners, LLC, on December 28, 2022.

 

"The combination of Edge and ZEON offers our customers unprecedented security with a simplified supply chain underpinned by the parent company's long-term track record of growth and success," said Edge's CEO Andrew Kamholz, Ph.D., "Edge can now further optimize both its proprietary thermal compression tooling and scale manufacturing technologies, offering the only product-quality process that requires no bridge tooling between prototyping and large-volume production."

 

ZEON's COPs (product names ZEONEX® and ZEONOR®), well known for their unique properties such as low autofluorescence, high light transmittance, low biomolecules adsorption, low impurities, and low melt viscosity, have been the leading material used for microscale and microfluidic and biochemical analysis applications

 

Through the acquisition of Edge, which uses many of ZEON's materials, ZEON will strengthen COP's use for microfluidic analytical devices while leveraging EDGE's customer network, including that of Aurora Microplates for microplates, acquired in February 2022. This latest move by ZEON aims at developing new businesses for cyclo olefin polymers (COPs) while expanding their commitment to explore new businesses in healthcare and life sciences

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close